Effect and underlying mechanism of resveratol on porcine primary preadipocyte apoptosis

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 26, Issue 8, 2010, Pages 1042-1049

  Zhang, Zhao ^a   Yang, Yang ^a   Pang, Weijun ^a   Sun, Chao ^a   Yang, Gongshe ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

Caspase 3; Porcine primary preadipocyte; Resveratrol; Sirt1

Indexed keywords

ANTIOXIDANT; CASPASE 3; RESVERATROL; SIRTUIN 1; STILBENE DERIVATIVE;

ADIPOCYTE; ADIPOGENESIS; ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; METABOLISM; SWINE;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CASPASE 3; CELLS, CULTURED; SIRTUIN 1; STILBENES; SWINE;

SUS;

EID: 78049454456     PISSN: 10003061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Prins J, O'Rahilly S. Regulation of adipose cell number in man. Clin Sci (Lond), 1997, 92: 3-11.
2. Fremont L. Biological effects of resveratrol. Life Sci, 2000, 66 (8): 663-673.
3. Rayalam S, Yang JY, Ambati S, et al. Resveratrol induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Phytother Res, 2008, 22 (10): 1367-1371.
4. Borra M, Smith B, Denu J. Mechanism of human SIRT1 activation by resveratrol. J Biol Chem, 2005, 280 (17): 17187-17195.
5. Yamamoto H, Schoonjans KJA. Sirtuin functions in health and disease. Mol Endocrinol, 2007, 21 (8): 1745-1755.
6. Picard F, Kurtev M, Chung N, et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature, 2004, 429: 771-776.
7. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 [alpha]. Cell, 2006, 127 (6): 1109-1122.
8. Baur J, Pearson K, Price N, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 2006, 444 (7117): 337-342.
9. Bai L, Pang W, Yang Y, et al. Modulation of Sirt1 by resveratrol and nicotinamide alters proliferation and differentiation of pig preadipocytes. Mol Cell Biochem, 2008, 307 (1): 129-140.
10. Guarente L. Sirtuins as potential targets for metabolic syndrome. Nature, 2006, 444 (7121): 868-874.
11. Duprez L, Wirawan E, Berghe TV, et al. Major cell death pathways at a glance. Microbes Infect, 2009, 11 (13): 1050-1062.
12. Park J, Choi Y, Suh S, et al. Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis, 2001, 22 (10): 1633-1639.
13. Gross A, McDonnell J, Korsmeyer S. BCL-2 family members and the mitochondria in apoptosis. Genes Dev, 1999, 13 (15): 1899-1911.
14. Langley E, Pearson M, Faretta M, et al. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J, 2002, 21 (10): 2383-2396.
15. Yeung F, Hoberg JE, Ramsey CS. Modulation of NF-κ B-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J, 2004, 23 (12): 2369-2380.
16. Hwang C, Loftus T, Mandrup S, et al. Adipocyte differentiation and leptin expression. Annu Rev Devl Biol, 1997, 13 (1): 231-259.
17. Ailhaud G. Cell surface receptors, nuclear receptors and ligands that regulate adipose tissue development. Clin Chim Acta, 1999, 286: 181-190.
18. Alkhouri N, Gornicka A, Berk MP, et al. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J Biol Chem, 2010, 285 (5): 3428-3438.
19. Sorisky A, Magun R, Gagnon AM. Adipose cell apoptosis: Death in the energy depot. Int J Obes Relat Metab Disord, 2000, 24 (Suppl 4): S3-7.
20. Magun R, Gagnon A, Yaraghi Z, et al. Expression and regulation of neuronal apoptosis inhibitory protein during adipocyte differentiation. Diabetes, 1998, 47 (12): 1948-1952.
21. Magun R, Boone DL, Tsang BK. The effect of adipocyte differentiation on the capacity of 3T3-L1 cells to undergo apoptosis in response to growth factor deprivation. Int J Obes Relat Metab Disord, 1998, 22: 567-571.
22. Papineau D, Gagnon A, Sorisky A. Apoptosis of human abdominal preadipocytes before and after differentiation into adipocytes in culture. Metabolism, 2003, 52 (8): 987-992.
23. Yang GS, Zhang HW, Bai L. Pig-a ideal study animal model of obesity and diabeties. Prog Nat Sci, 2008, 18 (5): 481-487.
24. Yang J, Della-Fera M, Rayalam S, et al. Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci, 2008, 82 (19/20): 1032-1039.
25. Liang Y, Tsai S, Chen L, et al. Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochem Pharmacol, 2003, 65 (7): 1053-1060.
26. Estrov Z, Shishodia S, Faderl S, et al. Resveratrol blocks interleukin-1 B-induced activation of the nuclear transcription factor NF-kB, inhibits proliferation, causes S-phase arrest, and induces apoptosis of acute myeloid leukemia cells. Blood, 2003, 102: 987-995.
27. Haider U, Sorescu D, Griendling K, et al. Resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. Mol Pharmacol, 2003, 63 (4): 925-932.
28. Griswold A, Chang K, Runko A, et al. Sir2 mediates apoptosis through JNK-dependent pathways in Drosophila. Proc Natl Acad Sci USA, 2008, 105 (25): 8673-8678.